The Arctic Group is a leading, independent provider of financial services

Companies and services

Want a career at Arctic?

Apply now

Coronavirus (COVID-19) company policy

Arctic's response to the coronavirus situation

Read More

Download the
Arctic Circle app

Bestill LEI-nummer

Imøtekom kravet for investeringsselskap i 2018

Les mer

Update Client Information

For those who have received a request to update their client information.

Update now

News and latest activity

News and latest activity

Wed 25 Nov 2020

Job Openings - Arctic Business Management AS - Oslo - Senior Business Manager/Controller - Eiendom

Arctic er en av de største aktørene i Norge innenfor prosjektfinansiering av eiendom. Arctic Business Management AS har i dag 18 ansatte og forvalter en av Norges største eiendomsporteføljer. Selskapet er i en spennende utvikling og ønsker å utvide teamet med dyktige og engasjerte medarbeidere.

Thu 26 Nov 2020

News - Homely AS - NOK 55m - Private Placement

Arctic acted as Sole Manager in relation to the Private Placement of NOK 55 million in Homely AS. The Private Placement attracted strong interest from existing shareholders and selected Norwegian quality investors. We are grateful for the vote of confidence and congratulate on the successful transaction.

Fri 20 Nov 2020

Offerings - Copperstone Resources AB (publ) - Rights issue of SEK 160m

Arctic Securities is acting as financial advisor in relation to the rights issue in Copperstone Resources AB (publ). Copperstone Resources AB (publ) is referred to as “Copperstone” or “the Company”. Shareholders have pre-emptive rights to subscribe for shares. Two (2) existing shares of held on the record date of January 7, 2021 entitles to one (1) new share at a subscription price of SEK 0.5 per share. The subscription period runs 11 January – 25 January 2021. A Swedish prospectus and subscription note will be available before the subscription period on Copperstone’s website, and Arctic Securities website.

Mon 16 Nov 2020

News - Moderna provides second COVID-19 vaccine hit with trial data

It was only a week ago that Pfizer and Biontech collaboratively announced that their COVID-19 vaccine candidate was “more than 90% effective” in preventing infections due to SARS-CoV-2 after a first interim readout from a large Phase 3 study. Today, Arctic Aurora LifeScience’s portfolio company Moderna announced a similar efficacy readout, showing 94.5% vaccine efficacy from their study.

Latest from Twitter